Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Exelixis
Exelixis
Exelixis Drug Slows Kidney Cancer In New Chance For Embattled Biotech
Forbes
Mon, 07/20/15 - 09:07 am
Exelixis
kidney cancer
Cometriq
3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
Motley Fool
Thu, 07/16/15 - 02:27 pm
biotech
Xoma
Exelixis
Threshold Pharmaceuticals
Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"
Motley Fool
Sun, 07/5/15 - 11:03 am
Exelixis
Cobimetinib
vemurafenib
Cometriq
FDA taps the brakes on Genentech's cobimetinib review
Fierce Biotech
Wed, 07/1/15 - 04:08 pm
FDA
Genentech
Cobimetinib
melanoma
Exelixis
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
3 Biotech Stocks in Danger of Running Out of Cash
Motley Fool
Thu, 04/2/15 - 10:08 am
Galena Biopharma
Exelixis
Amarin
Roche and Exelixis roll toward FDA approval with a melanoma cocktail
Fierce Biotech
Thu, 02/19/15 - 10:41 am
Roche
Exelixis
FDA
melanoma
Cobimetinib
Zelboraf
BRAF inhibitor
Does This Drug Offer Exelixis Inc. Investors Hope for the Future?
Motley Fool
Fri, 01/2/15 - 08:25 am
Exelixis
Cobimetinib
melanoma
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
3 Biotech Stocks That Could Double in 2015
Motley Fool
Mon, 12/29/14 - 11:06 am
NPS Pharmaceuticals
Shire
Exelixis
Geron
Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact
Seeking Alpha
Tue, 12/16/14 - 08:08 am
Exelixis
cobemetinib
Roche
Genentech
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Seeking Alpha
Mon, 12/1/14 - 11:31 am
Exelixis
prostate cancer
cabozantinib
Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists
Forbes
Thu, 09/4/14 - 08:29 am
Piramal Healthcare
Exelixis
Novo Nordisk
R&D
Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
TheStreet.com
Tue, 09/2/14 - 07:54 am
Exelixis
prostate cancer
cabozantinib
layoffs
This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results
Motley Fool
Sun, 07/20/14 - 09:14 am
Progenics Pharmaceuticals
Salix
Exelixis
Roche
Amgen
AbbVie
Shire
Should Roche Buy Exelixis?
Motley Fool
Thu, 07/17/14 - 08:54 am
Exelixis
M&A
Roche
Cobimetinib
Zelboraf
Roche, Exelixis Skin Cancer Drug Delays Tumor Progression
TheStreet.com
Mon, 07/14/14 - 10:32 am
Roche
Exelixis
melanoma
Cobimetinib
Zelboraf
Big Pharma Needs Growth: Two Severely Undervalued Companies Ripe for a Takeover
Wall St Cheat Sheet
Sun, 07/6/14 - 10:12 am
Exelixis
Synta Pharmaceuticals
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »